- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
Patent holdings for IPC class C07K 16/40
Total number of patents in this class: 4705
10-year publication summary
|
398
|
512
|
444
|
427
|
431
|
429
|
435
|
381
|
382
|
119
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
121 |
| Genentech, Inc. | 3742 |
119 |
| Hoffmann-La Roche Inc. | 3060 |
92 |
| F. Hoffmann-La Roche AG | 7958 |
85 |
| Omeros Corporation | 286 |
78 |
| Amgen Inc. | 3779 |
76 |
| Takeda Pharmaceutical Company Limited | 2961 |
76 |
| aTyr Pharma, Inc. | 158 |
73 |
| Pangu BioPharma Limited | 106 |
69 |
| The Regents of the University of California | 18943 |
65 |
| Immatics Biotechnologies GmbH | 1144 |
48 |
| University of Leicester | 211 |
45 |
| Novartis AG | 11238 |
38 |
| Kymab Limited | 229 |
34 |
| Mayo Foundation for Medical Education and Research | 2981 |
33 |
| The Johns Hopkins University | 5377 |
29 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
29 |
| Roche Glycart AG | 144 |
28 |
| Pfizer Inc. | 3322 |
27 |
| The Trustees of the University of Pennsylvania | 4122 |
26 |
| Other owners | 3514 |